Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

807 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Protein restriction slows the development and progression of Alzheimer's disease in mice.
Babygirija R, Sonsalla MM, Mill J, James I, Han JH, Green CL, Calubag MF, Wade G, Tobon A, Michael J, Trautman MM, Matoska R, Yeh CY, Grunow I, Pak HH, Rigby MJ, Baldwin DA, Niemi NM, Denu JM, Puglielli L, Simcox J, Lamming DW. Babygirija R, et al. Among authors: mill j. Res Sq [Preprint]. 2024 Apr 24:rs.3.rs-3342413. doi: 10.21203/rs.3.rs-3342413/v2. Res Sq. 2024. Update in: Nat Commun. 2024 Jun 18;15(1):5217. doi: 10.1038/s41467-024-49589-z PMID: 37790423 Free PMC article. Updated. Preprint.
Protein restriction slows the development and progression of pathology in a mouse model of Alzheimer's disease.
Babygirija R, Sonsalla MM, Mill J, James I, Han JH, Green CL, Calubag MF, Wade G, Tobon A, Michael J, Trautman MM, Matoska R, Yeh CY, Grunow I, Pak HH, Rigby MJ, Baldwin DA, Niemi NM, Denu JM, Puglielli L, Simcox J, Lamming DW. Babygirija R, et al. Among authors: mill j. Nat Commun. 2024 Jun 18;15(1):5217. doi: 10.1038/s41467-024-49589-z. Nat Commun. 2024. PMID: 38890307 Free PMC article.
Integrative metabolomics science in Alzheimer's disease: Relevance and future perspectives.
Lista S, González-Domínguez R, López-Ortiz S, González-Domínguez Á, Menéndez H, Martín-Hernández J, Lucia A, Emanuele E, Centonze D, Imbimbo BP, Triaca V, Lionetto L, Simmaco M, Cuperlovic-Culf M, Mill J, Li L, Mapstone M, Santos-Lozano A, Nisticò R. Lista S, et al. Among authors: mill j. Ageing Res Rev. 2023 Aug;89:101987. doi: 10.1016/j.arr.2023.101987. Epub 2023 Jun 19. Ageing Res Rev. 2023. PMID: 37343679 Review.
Immunogenicity and Safety According to Immunosuppressive Drugs and Different COVID-19 Vaccine Platforms in Immune-Mediated Disease: Data from SAFER Cohort.
Machado KLLL, Burian APN, Martins-Filho OA, Mill JG, Ferreira LB, Tapia KRL, Moulin ACS, Moulaz IR, Ribeiro PDC, Magalhães VO, Biegelmeyer E, Peixoto FMMMC, Ribeiro SLE, Telles CMPF, Bühring J, Sartorio NS, Hax V, Rezende RPV, Baptista KL, Melo AKG, Cruz VA, Vieira RMRA, Azevedo RH, Azevedo VF, Pinheiro MM, Monticielo OA, Reis Neto ETD, Teixeira-Carvalho A, Xavier RM, Sato EI, de Souza VA, Ferreira GA, Pileggi GS, Valim V. Machado KLLL, et al. Among authors: mill jg. Vaccines (Basel). 2024 Dec 3;12(12):1367. doi: 10.3390/vaccines12121367. Vaccines (Basel). 2024. PMID: 39772029 Free PMC article.
807 results